(19)

(11)

EP 4 739 683 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 23741602.9 (22) Date of filing: 05.07.2023

(51) International Patent Classification (IPC):  C07D 471/04(2006.01) C07D 401/12(2006.01) A61P 35/00(2006.01) A61K 31/47(2006.01) C07D 217/04(2006.01) C07D 401/14(2006.01) A61K 31/4375(2006.01) (52) Cooperative Patent Classification (CPC): C07D 471/04; A61P 35/00; C07D 401/14; C07D 401/12; C07D 217/04 (86) International application number: PCT/EP2023/068561 (87) International publication number: WO 2025/008059 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (71) Applicant: Janssen Pharmaceutica NV 2340 Beerse (BE)	(72) Inventors: STANSFIELD, Ian 2340 Beerse (BE) LEONARD, Kristi Anne Raritan, New Jersey 08869 (US) WINTERS, Michael Peter Raritan, New Jersey 08869 (US) BERTHELOT, Didier Jean Claude 2340 Beerse (BE) (74) Representative: Campabadal Monfa, Gemma  Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse 2340 Beerse (BE)